PD02 Evolving Telemedicine Perspectives And Capacities To Meet Countrywide Breast Cancer Screening Demands

Sep 29, 2026

Uploaded by Theodore

Telemedicine capacity evolution is leveraged to strengthen cost-effective breast cancer screening, especially for underserved hospitals. This descriptive study evaluates a telemedicine-driven breast cancer diagnostic network implemented in remote public hospitals in Paraguay. It assesses the platform’s diagnostic types and frequencies and reports 840 screening tests across 34 hospitals from October to November 2024, producing normal, cyst, and other findings. Results support timely, high-quality tertiary diagnostics with equitable access, while wider adoption evaluation remains required before rollout.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages1

Reading Time3 min

AccessFree to download

PD02 Evolving Telemedicine Perspectives And Capacities To Meet Countrywide Breast Cancer Screening Demands

Introduction

Methods

Results

Conclusions

PD03 Diagnostic Accuracy Of Liquid Biopsy In Breast, Lung, And Colorectal Cancer

Introduction

Methods

Results

Conclusions

PD04 Economic Evaluation Of Neonatal Screening Strategies For Congenital Cytomegalovirus In Spain

Introduction

Methods

S40 Poster Presentations (online) PD02 Evolving Telemedicine Perspectives And Capacities To Meet Countrywide Breast Cancer Screening Demands Pedro Galvan ([pedro.galvan@upa.edu.py](pedro.galvan@upa.edu.py)), Jose Ortellado, Santiago Garcia, Maria Teresa Baran and Enrique Hilario Introduction: Telemedicine capacity has evolved and currently offers excellent tools for fortifying health screening systems, particularly for building a cost-effective screening network for the early diagnosis of breast cancer. In this context, a telemedicine driven approach should be directed toward improving breast cancer screening innovation in underserved hospitals. This study evaluated the results of a telemedicine-driven breast cancer diagnostic network in remote public hospitals in Paraguay. Methods: This is a descriptive study, where the results using telemedicine-driven breast cancer diagnosis innovations in remote public hospitals were evaluated for their ability to improve accessibility and equity to specialized diagnostic services countrywide. For this purpose, the type and frequency of diagnoses performed through a telemedicine platform was determined. Results: During the study, a digital telemedicine-driven breast cancer screening network was implemented in 34 hospitals countrywide. The screening procedure involved analyzing a digitally acquired mammogram for masses, calcifications, or areas of abnormal density that may indicate the presence of cancer. The implemented cancer screening network performed 840 tests between October and November 2024 . This resulted in the following diagnoses: normal (60%); cyst (33%); and fibroadenoma, macrocalcifications, and abnormal area (7%) . If there is a significant suspicion of cancer, then tissue will be removed for a biopsy and examined by a pathologist. Conclusions: According to our results, the telemedicine-driven breast cancer screening innovation network facilitated a timely, pertinent, high-quality tertiary level diagnostic service with equitable access for patients in remote underserved public hospitals in Paraguay. A widespread use assessment is necessary before this breast cancer screening method can be implemented. PD03 Diagnostic Accuracy Of Liquid Biopsy In Breast, Lung, And Colorectal Cancer Anna Godo Pla, Maria Dolors Estrada Sabadell and Rosa Maria Vivanco-Hidalgo (rvivanco@gencat.cat) Introduction: Liquid biopsy (LB) is a minimally invasive technique that enables analysis of circulating tumor DNA (ctDNA) by next generation sequencing (NGS) and has several potential applications in oncology. The main objective was to describe the diagnostic accuracy of LB over tissue biopsy for screening, diagnosis, and tumor mutation profiling in breast, lung, and colorectal cancer, including at different cancer stages. Methods: Initially, a literature overview to select systematic reviews with meta-analyses or health technology assessment reports was conducted. When no data were obtained, a systematic review was conducted to select individual studies. For both procedures, a systematic literature search, two-step study selection, quality appraisal and a narrative synthesis were conducted. Results: The only study in the screening setting involved colorectal cancer (sensitivity 14%, specificity 90%) . Regarding initial cancer diagnosis, LB in breast cancer had a sensitivity ranging from 31 to 74 percent and a specificity of 66 to 92 percent, with inconsistent results by stage. For lung cancer, LB had a sensitivity of 22 to 86 percent and a specificity of 42 to 91 percent, with improved utility in advanced stages. Colorectal cancer studies using multicomponent tests showed sensitivities of 83 to 93 percent and specificities of more than 95% . LB ctDNA analysis in molecular profiling of advanced cancer had high accuracy in breast (PIK3CA), lung (epidermal growth factor receptor mutations), and colorectal cancer (NRAS/ KRAS), with values for sensitivity of up to 83 percent and for

FAQs

What problem does the PD02 study address?

It targets how telemedicine can strengthen breast cancer screening capacity, particularly by building a cost-effective screening network for early diagnosis in underserved hospitals in Paraguay.

How was telemedicine used in the PD02 screening network?

A digital mammogram was analyzed for masses, calcifications, and abnormal density areas, with suspicious cases proceeding to tissue removal for biopsy and pathologist examination.

What did the PD02 study conclude about diagnostic quality and access?

The telemedicine-driven screening innovation enabled timely, pertinent, high-quality tertiary diagnostic services with equitable access for patients in remote underserved public hospitals; broader use assessment is still needed before implementation.

Sep 29, 2026

Uploaded by Theodore